Evidence map›Paper›PMID 30268102›Full record

ArticleBMC infectious diseases2018

Carbapenem susceptibilities of Gram-negative pathogens in intra-abdominal and urinary tract infections: updated report of SMART 2015 in China.

Hui Zhang, Haishen Kong, Yunsong Yu, Anhua Wu, Qiong Duan, Xiaofeng Jiang, Shufang Zhang, Ziyong Sun, Yuxing Ni, Weiping Wang and 10 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Emergence ofMicrobiology spectrum · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Infection and drug resistance · 2019
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 17 institutions in 1 country.

Hui ZhangDivision of Microbiology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, No. 1 Shuaifuyuan, Wangfujing Street, Beijing, 100730, China.
Haishen KongDepartment of Microbiology, The First Affiliated Hospital of Zhejiang University, Hangzhou, 310003, China.
Yunsong YuDepartment of Infectious Diseases, SirRunRun Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, 310016, China.
Anhua WuInfection Control Center, Xiangya Hospital, Central South University, Changsha, 410008, China.
Qiong DuanMicrobiology Laboratory, Jilin Province People's Hospital, Changchun, 130021, China.
Xiaofeng JiangThe Fourth Hospital of Harbin Medical University, No. 37 Yiyuan Road, Nangang District, Harbin, China.
Shufang ZhangDivision of Microbiology, Haikou People's Hospital, Haikou, 570208, China.
Ziyong SunDepartment of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Yuxing NiDivision of Microbiology, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200025, China.
Weiping WangNanjing General Hospital, No. 305 Zhongshan Dong Road, Nanjing, China.
Yong WangDepartment of Laboratory Medicine, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, 250021, China.
Kang LiaoDivision of Microbiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, China.
Huayin LiZhongshan Hospital Affiliated to Fudan University, No. 180 Fenglin Road, Shanghai, 200032, China.
Chunxia YangBeijing Chao-yang Hospital, 8 Gongren Tiyuchang Nanlu, Chaoyang District, Beijing, 100020, China.
Wenxiang HuangDivision of Microbiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Bingdong GuiClinical laboratory, The Second Affiliated Hospital of Nanchang University, Nanchang, 330006, China.
Bin ShanFirst Affiliated Hospital of Kunming Medical University, No. 295 Xichang Road, Kunming, 650032, China.
Robert BadalDivision of Microbiology, International Health Management Associates, Schaumburg, IL, 60173-3817, USA.
Qiwen YangDivision of Microbiology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, No. 1 Shuaifuyuan, Wangfujing Street, Beijing, 100730, China. yangqiwen81@163.com.
Yingchun XuDivision of Microbiology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, No. 1 Shuaifuyuan, Wangfujing Street, Beijing, 100730, China. xycpumch@139.com.ORCID http://orcid.org/0000-0002-9457-5635
Chinese Academy of Medical Sciences & Peking Union Medical College · CNBeijing Chao-Yang Hospital, Capital Medical University · CNCentral South University · CNFirst Affiliated Hospital Zhejiang University · CNFudan University · CNHaikou City People's Hospital · CNHarbin Medical University · CNKunming Medical University · CNNanchang University · CNNanjing General Hospital of Nanjing Military Command · CNPeople 's Hospital of Jilin Province · CNRuijin Hospital · CNShandong University · CNSir Run Run Shaw Hospital · CNSun Yat-sen University · CNThe Affiliated Yongchuan Hospital of Chongqing Medical University · CNTongji Hospital · CN

Funding

CAMS Initiative for Innovative Medicine 2016-I2M-3-014CAMS Innovation Fund for Medical Sciences (CIFMS) 2016-I2M-1-014The National Key Research and Development Program of China SQ2018YFC120102
6 · The paper itself

Abstract

backgroundTo evaluate the susceptibility rates of aerobic and facultative Gram-negative bacterial isolates from Chinese intra-abdominal infections (IAI) and urinary tract infections (UTI) focusing on carbapenems and comparing their effectiveness between 2014 and 2015.

methodsA total of 2318 strains in 2015 (1483 from IAI and 835 from UTI) and 2374 strains in 2014 (1438 from IAI and 936 from UTI) were included in the analysis. Antimicrobial susceptibilities were determined at a central laboratory using CLSI broth microdilution and interpretive standards. Hospital acquired (HA) IAI and UTI were defined as isolates sampled > 48 h and community acquired (CA) as isolates sampled < 48 h after admission.

resultsThe main species derived from IAI and UTI in 2015 were Escherichia coli (50.86%) and Klebsiella pneumoniae (19.20%). Susceptibilities of Escherichia coli IAI and UTI strains to imipenem (IPM) and ertapenem (ETP) were > 90% in 2014 and 2015, while the susceptibilities to IPM and ETP of Klebsiella pneumoniae IAI strains were >  80% in 2014 but dropped to ≤80% in 2015 for UTI strains. Susceptibilities of IAI Enterobacteriaceae strains to IPM and ETP in 2015 were lowest in the colon and abscesses, and Enterobacteriaceae susceptibilities of UTI and IAI isolates to IPM and ETP were lowest in medical, pediatric and surgery intensive care units (ICUs) in 2015.

conclusionsIPM and ETP were effective in vitro against Enterobacteriaceae isolated from IAIs and UTIs in 2014 and 2015, but susceptibility to carbapenems in UTIs markedly decreased in 2015.

Indexed as

Anti-Bacterial Agentsbeta-LactamsChinaEnterobacteriaceaeErtapenemEscherichia coliGram-Negative BacteriaHumansImipenemIntraabdominal InfectionsKlebsiella pneumoniaeMicrobial Sensitivity TestsUrinary Tract InfectionsAnti-Bacterial Agentsbeta-LactamsErtapenemImipenemCarbapenem; ertapenemEnterobacteriaceaeImipenemIntra-abdominal infectionUrinary tract infection

Identifiers

PMID30268102
PMCPMC6162895
OpenAlexW2894412476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.